# Gold.com, Inc.: financial statements, quarterly GOLD · NYSE · CIK 1591588 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/gold.md) · [Financials](/companies/gold/financials.md) · [Filings](/companies/gold/filings.md) · [Insiders](/companies/gold/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gold/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [2.5](/filings/0000950170-24-124015.md) | [2.1](/filings/0000950170-25-016909.md) | [2.6](/filings/0000950170-25-069268.md) | [2.5 d](/filings/0001193125-26-386799.md) | [2.7](/filings/0001193125-25-272399.md) | [2.7](/filings/0001193125-26-041321.md) | [0.0](/filings/0001193125-26-215252.md) | [0.1 d](/filings/0001193125-26-386799.md) | [3.7](/filings/0001193125-25-272399.md) | [0.1](/filings/0001193125-26-041321.md) | [0.2](/filings/0001193125-26-215252.md) | [0.2 d](/filings/0001193125-26-386799.md) | | Cost of revenue | $bn | [2.4](/filings/0000950170-24-124015.md) | [2.0](/filings/0000950170-25-016909.md) | [2.6](/filings/0000950170-25-069268.md) | [2.5 d](/filings/0001193125-26-386799.md) | [2.7](/filings/0001193125-25-272399.md) | [2.7](/filings/0001193125-26-041321.md) | [3.0](/filings/0001193125-26-215252.md) | [2.4 d](/filings/0001193125-26-386799.md) | [3.6](/filings/0001193125-25-272399.md) | [6.4](/filings/0001193125-26-041321.md) | [10.2](/filings/0001193125-26-215252.md) | [4.9 d](/filings/0001193125-26-386799.md) | | Gross profit | $bn | [0.0](/filings/0000950170-24-124015.md) | [0.0](/filings/0000950170-25-016909.md) | [0.0](/filings/0000950170-25-069268.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [0.0](/filings/0001193125-26-215252.md) | [0.1 d](/filings/0001193125-26-386799.md) | [0.1](/filings/0001193125-25-272399.md) | [0.1](/filings/0001193125-26-041321.md) | [0.2](/filings/0001193125-26-215252.md) | [0.1 d](/filings/0001193125-26-386799.md) | | Selling, general and administrative | $bn | [0.0](/filings/0000950170-24-124015.md) | [0.0](/filings/0000950170-25-016909.md) | [0.0](/filings/0000950170-25-069268.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [0.0](/filings/0001193125-26-215252.md) | [0.1 d](/filings/0001193125-26-386799.md) | [0.1](/filings/0001193125-25-272399.md) | [0.1](/filings/0001193125-26-041321.md) | [0.1](/filings/0001193125-26-215252.md) | [0.1 d](/filings/0001193125-26-386799.md) | | Interest expense | $bn | [0.0](/filings/0000950170-24-124015.md) | [0.0](/filings/0000950170-25-016909.md) | [0.0](/filings/0000950170-25-069268.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [0.0](/filings/0001193125-26-215252.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [0.0](/filings/0001193125-26-215252.md) | [0.0 d](/filings/0001193125-26-386799.md) | | Income tax | $bn | [0.0](/filings/0000950170-24-124015.md) | [0.0](/filings/0000950170-25-016909.md) | [0.0](/filings/0000950170-25-069268.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [(0.0)](/filings/0001193125-26-215252.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [0.0](/filings/0001193125-26-215252.md) | [0.0 d](/filings/0001193125-26-386799.md) | | Net income | $bn | [0.0](/filings/0000950170-24-124015.md) | [0.0](/filings/0000950170-25-016909.md) | [0.0](/filings/0000950170-25-069268.md) | [0.0 d](/filings/0001193125-26-386799.md) | [0.0](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [(0.0)](/filings/0001193125-26-215252.md) | [0.0 d](/filings/0001193125-26-386799.md) | [(0.0)](/filings/0001193125-25-272399.md) | [0.0](/filings/0001193125-26-041321.md) | [0.1](/filings/0001193125-26-215252.md) | [0.0 d](/filings/0001193125-26-386799.md) | | Diluted EPS | $ per share | [0.77](/filings/0000950170-24-124015.md) | [0.57](/filings/0000950170-25-016909.md) | [0.21](/filings/0000950170-25-069268.md) | not reported | [0.37](/filings/0001193125-25-272399.md) | [0.27](/filings/0001193125-26-041321.md) | [(0.36)](/filings/0001193125-26-215252.md) | not reported | [(0.04)](/filings/0001193125-25-272399.md) | [0.46](/filings/0001193125-26-041321.md) | [2.09](/filings/0001193125-26-215252.md) | not reported | | Basic EPS | $ per share | [0.81](/filings/0000950170-24-124015.md) | [0.60](/filings/0000950170-25-016909.md) | [0.22](/filings/0000950170-25-069268.md) | not reported | [0.39](/filings/0001193125-25-272399.md) | [0.28](/filings/0001193125-26-041321.md) | [(0.36)](/filings/0001193125-26-215252.md) | not reported | [(0.04)](/filings/0001193125-25-272399.md) | [0.47](/filings/0001193125-26-041321.md) | [2.17](/filings/0001193125-26-215252.md) | not reported | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current assets | $m | [1,295](/filings/0000950170-23-061277.md) | [1,340](/filings/0000950170-24-012899.md) | [1,349](/filings/0000950170-24-057222.md) | [1,442](/filings/0001193125-25-200462.md) | [1,646](/filings/0000950170-24-124015.md) | [1,490](/filings/0000950170-25-016909.md) | [1,758](/filings/0000950170-25-069268.md) | [1,743](/filings/0001193125-26-386799.md) | [2,111](/filings/0001193125-25-272399.md) | [3,342](/filings/0001193125-26-041321.md) | [3,668](/filings/0001193125-26-215252.md) | [3,604](/filings/0001193125-26-386799.md) | | Total assets | $m | [1,579](/filings/0000950170-23-061277.md) | [1,624](/filings/0000950170-24-012899.md) | [1,669](/filings/0000950170-24-057222.md) | [1,828](/filings/0001193125-25-200462.md) | [2,029](/filings/0000950170-24-124015.md) | [1,869](/filings/0000950170-25-016909.md) | [2,184](/filings/0000950170-25-069268.md) | [2,215](/filings/0001193125-26-386799.md) | [2,579](/filings/0001193125-25-272399.md) | [3,812](/filings/0001193125-26-041321.md) | [4,174](/filings/0001193125-26-215252.md) | [4,137](/filings/0001193125-26-386799.md) | | Current liabilities | $m | [705](/filings/0000950170-23-061277.md) | [720](/filings/0000950170-24-012899.md) | [765](/filings/0000950170-24-057222.md) | [884](/filings/0001193125-25-200462.md) | [990](/filings/0000950170-24-124015.md) | [945](/filings/0000950170-25-016909.md) | [1,129](/filings/0000950170-25-069268.md) | [1,114](/filings/0001193125-26-386799.md) | [1,543](/filings/0001193125-25-272399.md) | [2,754](/filings/0001193125-26-041321.md) | [3,119](/filings/0001193125-26-215252.md) | [3,147](/filings/0001193125-26-386799.md) | | Total liabilities | $m | [996](/filings/0000950170-23-061277.md) | [1,038](/filings/0000950170-24-012899.md) | [1,082](/filings/0000950170-24-057222.md) | [1,166](/filings/0001193125-25-200462.md) | [1,364](/filings/0000950170-24-124015.md) | [1,204](/filings/0000950170-25-016909.md) | [1,487](/filings/0000950170-25-069268.md) | [1,513](/filings/0001193125-26-386799.md) | [1,882](/filings/0001193125-25-272399.md) | [3,103](/filings/0001193125-26-041321.md) | [3,267](/filings/0001193125-26-215252.md) | [3,199](/filings/0001193125-26-386799.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [582](/filings/0000950170-23-061277.md) | [584](/filings/0000950170-24-012899.md) | [583](/filings/0000950170-24-057222.md) | [608](/filings/0001193125-25-200462.md) | [611](/filings/0000950170-24-124015.md) | [613](/filings/0000950170-25-016909.md) | [644](/filings/0000950170-25-069268.md) | [650](/filings/0001193125-26-386799.md) | [644](/filings/0001193125-25-272399.md) | [654](/filings/0001193125-26-041321.md) | [847](/filings/0001193125-26-215252.md) | [876](/filings/0001193125-26-386799.md) | - Cash and equivalents: not reported - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(44.3)](/filings/0000950170-24-124015.md) | [(57.4) d](/filings/0000950170-25-016909.md) | [79.8 d](/filings/0000950170-25-069268.md) | [82.9 d](/filings/0001193125-26-386799.md) | [(128)](/filings/0001193125-25-272399.md) | [110 d](/filings/0001193125-26-041321.md) | [103 d](/filings/0001193125-26-215252.md) | [67.0 d](/filings/0001193125-26-386799.md) | [195](/filings/0001193125-25-272399.md) | [(42.6) d](/filings/0001193125-26-041321.md) | [0.2 d](/filings/0001193125-26-215252.md) | [1,070 d](/filings/0001193125-26-386799.md) | | Capital expenditure | $m | [1.9](/filings/0000950170-24-124015.md) | [1.9 d](/filings/0000950170-25-016909.md) | [0.7 d](/filings/0000950170-25-069268.md) | [2.7 d](/filings/0001193125-26-386799.md) | [0.6](/filings/0001193125-25-272399.md) | [3.7 d](/filings/0001193125-26-041321.md) | [2.5 d](/filings/0001193125-26-215252.md) | [3.9 d](/filings/0001193125-26-386799.md) | [2.0](/filings/0001193125-25-272399.md) | [4.0 d](/filings/0001193125-26-041321.md) | [3.2 d](/filings/0001193125-26-215252.md) | [3.5 d](/filings/0001193125-26-386799.md) | | Dividends paid | $m | [28.0](/filings/0000950170-24-124015.md) | [4.7 d](/filings/0000950170-25-016909.md) | [4.6 d](/filings/0000950170-25-069268.md) | [4.6 d](/filings/0001193125-26-386799.md) | [4.6](/filings/0001193125-25-272399.md) | [4.6 d](/filings/0001193125-26-041321.md) | [4.6 d](/filings/0001193125-26-215252.md) | [4.9 d](/filings/0001193125-26-386799.md) | [5.0](/filings/0001193125-25-272399.md) | [4.9 d](/filings/0001193125-26-041321.md) | [5.7 d](/filings/0001193125-26-215252.md) | [6.9 d](/filings/0001193125-26-386799.md) | | Share repurchases | $m | [4.9](/filings/0000950170-24-124015.md) | [12.0 d](/filings/0000950170-24-012899.md) | [5.4 d](/filings/0000950170-24-057222.md) | [0.0 d](/filings/0000950170-24-106317.md) | [0.0](/filings/0000950170-24-124015.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [24.7](/filings/0000950170-23-061277.md) | [24.7](/filings/0000950170-24-012899.md) | [24.7](/filings/0000950170-24-057222.md) | [24.5](/filings/0000950170-24-124015.md) | [24.1](/filings/0000950170-25-016909.md) | [23.8](/filings/0000950170-25-069268.md) | [24.0](/filings/0001193125-25-272399.md) | [24.0](/filings/0001193125-26-041321.md) | [23.6](/filings/0001193125-26-215252.md) | [24.7](/filings/0001193125-25-272399.md) | [25.5](/filings/0001193125-26-041321.md) | [28.4](/filings/0001193125-26-215252.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 29,154,756 at 2026-08-28, from the cover of the [10-K filed 2026-09-10](/filings/0001193125-26-386799.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.